Y-mAbs Therapeutics Inc (YMAB)
17.15
-0.10
(-0.58%)
USD |
NASDAQ |
May 03, 16:00
17.11
-0.04
(-0.23%)
After-Hours: 20:00
Y-mAbs Therapeutics Cash from Operations (TTM): -27.23M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -27.23M |
| September 30, 2023 | -27.86M |
| June 30, 2023 | -45.75M |
| March 31, 2023 | -64.12M |
| December 31, 2022 | -75.92M |
| September 30, 2022 | -101.12M |
| June 30, 2022 | -99.96M |
| March 31, 2022 | -95.62M |
| December 31, 2021 | -102.56M |
| September 30, 2021 | -86.39M |
| June 30, 2021 | -92.46M |
| Date | Value |
|---|---|
| March 31, 2021 | -101.34M |
| December 31, 2020 | -91.23M |
| September 30, 2020 | -98.12M |
| June 30, 2020 | -95.36M |
| March 31, 2020 | -81.77M |
| December 31, 2019 | -73.50M |
| September 30, 2019 | -62.50M |
| June 30, 2019 | -50.29M |
| March 31, 2019 | -48.10M |
| December 31, 2018 | -41.23M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-102.56M
Minimum
Dec 2021
-27.23M
Maximum
Dec 2023
-77.53M
Average
-86.39M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| The Cooper Companies Inc | 563.60M |
| Puma Biotechnology Inc | 27.01M |
| Humacyte Inc | -73.30M |
| Moderna Inc | -2.882B |
| NovaBay Pharmaceuticals Inc | -4.131M |